Gossamer Bio Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	2018 - 2016
Net Income	-172.58	-179.82	-229.38	-234	-243.36	-180.31	Upgrade
Depreciation & Amortization	4.23	4.39	4.43	5.17	4.27	3.09	Upgrade
Share-Based Compensation	26.2	28.52	42.55	32.01	38.75	20.82	Upgrade
Other Operating Activities	-16.32	-12.24	-4.64	7.94	23.98	11.57	Upgrade
Operating Cash Flow	-158.47	-159.16	-187.03	-188.89	-176.36	-144.83	Upgrade
Capital Expenditures	0	0	-0.41	-1.55	-1.5	-2.97	Upgrade
Acquisitions	0.02	0	-0.07	-0.08	-23.38	-3.6	Upgrade
Change in Investments	-58.03	-110.97	-0.56	-115.81	240.23	-140.58	Upgrade
Investing Cash Flow	-58.02	-110.97	-1.04	-117.43	215.34	-147.14	Upgrade
Share Issuance / Repurchase	201.75	201.77	122.9	3.33	118.94	293.36	Upgrade
Debt Issued / Paid	-11.61	-11.61	-5.81	0	193.6	28.22	Upgrade
Financing Cash Flow	190.14	190.15	117.09	3.33	312.54	321.58	Upgrade
Exchange Rate Effect	-0.02	0.11	-0.52	-0.17	0.01	0.07	Upgrade
Net Cash Flow	-26.38	-79.86	-71.49	-303.15	351.53	29.67	Upgrade
Free Cash Flow	-158.47	-159.16	-187.44	-190.44	-177.86	-147.8	Upgrade
Free Cash Flow Per Share	-0.70	-1.04	-2.22	-2.54	-2.60	-2.70	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).